We think that InMed’s proprietary technology could put $6.6 Billion in play and make it one of the strongest biotech stocks in the market. We also think InMed is in the right place at the right time to create real value for investors in the Industry. Here's a few reasons why.
India Globalization Capital, Inc. (NYSE American: IGC) this morning announced that it has entered into a memorandum of understanding with MediCann Handels GmbH.
ChineseInvestors.com continues to rapidly grow in 2017, which is primarily attributed to the company’s focus on the CBD health products market.
InMed announces results of a study co-sponsored with the University of British Columbia. The InMed-UBC study is the first ever to report hydrogel-mediated cannabinoid nanoparticle delivery to the eye, resulting in enhanced drug uptake via the cornea and lens. This study further validates the Company’s capacity to conduct a wide spectrum of drug development activities
Specialized holding company SinglePoint, Inc. (OTC: SING) and technology development company AppSwarm, Inc. (OTC: SWRM) this morning announced their entry into a Letter of Intent related to a joint roll-out of mobile applications specifically geared to the cannabis industry.
Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced that its majority owned subsidiary, MoneyTrac Technology, Inc., has established a strategic partnership with Pegasus Fintech, Inc.
Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced results from a study co-sponsored by InMed and the University of British Columbia.
PotNetwork Holding, Inc. (OTC: POTN) this morning announced that its wholly owned subsidiary, Diamond CBD, Inc., has enhanced its product line with a selection of premium honey products.
Grey Cloak Tech, Inc. (OTCQB: GRCK) this morning announced that it has acquired Eqova Life Sciences, a medically-focused CBD company, in an all-stock transaction.
EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis analytical testing services, this morning announced the opening of its fifth testing location in eastern Oregon.
Funding was oversubscribed by 20%, led by Aphria and Green Acre Capital.
Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced that it is in the final stages of performing a two-year audit in an effort to become a fully reporting SEC company.
MYM Nutraceuticals Inc., (CSE: MYM) announces it has closed the first tranche of its non-brokered private placement of 5,709,000 units at a price of $0.50 per unit for gross proceeds of $2,854,500.
Tweed Inc., wholly-owned subsidiary of Canopy Growth Corporation and DNA Holding LLC are proud to announce the renewal and expansion of their partnership through to October 2022. Together they are committed to bringing the best possible cannabis to Canada.
Global Payout, Inc. (OTCPink: GOHE) announces it is in the final stages of performing a 2-year audit to become a fully reporting SEC company. Upon completion of the audit, GOHE will immediately apply to be listed on the OTCQB Venture Marketplace..
